Ansella Therapeutics

📍 Lowell, United States👥 5 employees💰 Last funded 2018
Pharmaceutical Manufacturing🌐 ansellatx.com
Website LinkedIn
Ansella Therapeutics is a specialty pharmaceutical company that focuses on the often overlooked details of well-understood biological systems and leverages novel materials science to create new treatment options for women’s health. Our patented, bio-inspired platform technology gives rise to a pipeline of over-the-counter (OTC) and prescription products that target improving vaginal health at all stages in life. Our flagship personal lubricant product is a first-in-class, biomimetic cream that unlocks the potential of cholesterol and fatty acids to maintain favorable cellular properties in the vaginal epithelium. Ultimately, this product is designed to mimic cervical and vaginal secretions and interface well with the dynamic vaginal mucosa.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Ansella Therapeutics?
Ansella Therapeutics has 1 investors on record on gritt.io.
When did Ansella Therapeutics last raise funding?
The most recent investment in Ansella Therapeutics recorded on gritt.io was in 2018.
What industry is Ansella Therapeutics in?
Ansella Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Ansella Therapeutics based?
Ansella Therapeutics is headquartered in Lowell, United States.